Rhodium-Catalyzed Addition of Arylboronic Acids
7.70-7.66 (1H, m), 7.49-7.45 (1H, m), 7.35 (1H, d, J ) 8.0
Hz), 7.24-7.17 (4H, m), 6.50 (1H, s), 3.06 (2H, t, J ) 8.0 Hz),
2.39 (3H, s), 1.54-1.46 (2H, m), 1.43-1.33 (2H, m), 0.89 (3H,
t, J ) 7.2 Hz); 13C NMR (100 MHz, CDCl3) δ 156.9, 150.7,
148.1, 144.3, 135.7, 134.9, 130.2, 129.4, 129.3, 128.4, 128.4,
127.3, 126.9, 126.4, 125.9, 125.4, 122.8, 33.1, 30.2, 23.1, 20.0,
14.0; MS m/z 301 (M+); HRMS m/z calcd for C22H23N 301.1830
(M+), found 301.1837.
(E )-5-Br om o-2-[2-(2-m e t h ylp h e n yl)-1-h e xe n yl]p yr i-
d in e (37): Rf ) 0.61 (10% Et2O in hexane); IR (neat) 2956,
2857, 1634, 1568 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.66 (1H,
d, J ) 2.7 Hz), 7.73 (1H, dd, J ) 8.1 and 2.7 Hz), 7.19-7.08
(5H, m), 6.24 (1H, s), 2.88 (2H, t, J ) 7.5 Hz), 2.34 (3H, s),
1.43-1.22 (4H, m), 0.84 (3H, t, J ) 6.9 Hz); 13C NMR (75 MHz,
CDCl3) δ 155.2, 150.1, 149.8, 143.9, 138.4, 134.7, 130.1, 128.2,
126.8, 126.8, 125.3, 125.2, 117.7, 32.8, 30.1, 23.0, 20.0, 14.0;
MS m/z 329 (M+); HRMS m/z calcd for C18H20NBr 329.0779
(M+), found 329.0787.
CDCl3) δ 156.2, 147.8, 144.2, 135.8, 134.9, 130.0, 128.8, 128.4,
126.6, 125.2, 121.4, 32.7, 30.3, 23.1, 20.1, 14.1; MS m/z 423
(M+); HRMS m/z calcd for C31H37N 423.2926 (M+), found
423.2915.
(E)-5-(1-H exyn yl)-2-[2-(2-m et h ylp h en yl)-1-h exen yl]-
p yr id in e (44): Rf ) 0.56 (10% Et2O in hexane); IR (neat) 2957,
2871, 2230, 1634, 1587, 1538 cm-1; 1H NMR (300 MHz, CDCl3)
δ 8.62 (1H, d, J ) 1.5 Hz), 7.60 (1H, dd, J ) 8.1 and 1.5 Hz),
7.20-7.11 (5H, m), 6.28 (1H, s), 2.90 (2H, t, J ) 7.2 Hz), 2.44
(2H, t, J ) 6.9 Hz), 2.34 (3H, s), 1.65-1.55 (2H, m), 1.55-1.43
(2H, m), 1.41-1.23 (4H, m), 0.96 (3H, t, J ) 7.2 Hz), 0.83 (3H,
t, J ) 6.9 Hz); 13C NMR (75 MHz, CDCl3) δ 155.0, 151.6, 149.2,
144.1, 138.2, 134.8, 130.0, 128.3, 127.8, 126.7, 125.3, 123.2,
118.1, 93.7, 77.8, 32.8, 30.8, 30.2, 23.0, 22.1, 20.1, 19.3, 14.0,
13.7; MS m/z 331 (M+); HRMS m/z calcd for C24H29N 331.2300
(M+), found 331.2300.
(E)-2-[1-Deu t er io-2-(2-m et h ylp h en yl)-1-h exen yl]p yr i-
d in e (49): Rf ) 0.71 (50% Et2O in hexane); IR (neat) 3058,
2956, 2927, 2870, 1622, 1585, 1558 cm-1; 1H NMR (300 MHz,
CDCl3) δ 8.63-8.60 (1H, m), 7.62 (1H, ddd, J ) 7.8, 7.8, and
1.5 Hz), 7.24-7.15 (5H, m), 7.08 (1H, ddd, J ) 7.8, 4.8, and
1.8 Hz), 2.90 (2H, t, J ) 7.8 Hz), 2.36 (3H, s), 1.42-1.23 (4H,
m), 0.83 (3H, t, J ) 6.9 Hz); 13C NMR (75 MHz, CDCl3) δ 156.8,
149.1, 148.3, 144.0, 135.8, 134.8, 130.0, 128.3, 127.5(t), 126.7,
125.2, 123.9, 120.9, 32.5, 30.2, 23.0, 20.1, 14.0; MS m/z 252
(M+); HRMS m/z calcd for C18H20DN 252.1736 (M+), found
252.1738.
(E)-2-[2-(2-Met h ylp h en yl)-3-p h en yl-1-p r op en yl]p yr i-
d in e (38): Rf ) 0.71 (50% Et2O in hexane); IR (neat) 3060,
3025, 2922, 1634, 1585, 1558 cm-1; 1H NMR (400 MHz, CDCl3)
δ 8.68-8.67 (1H, m), 7.65 (1H, ddd, J ) 7.6, 7.6, and 1.6 Hz),
7.25 (1H, d, J ) 7.6 Hz), 7.16-6.98 (10H, m), 6.43 (1H, s),
4.43 (2H, s), 2.20 (3H, s); 13C NMR (100 MHz, CDCl3) δ 156.6,
149.2, 146.1, 143.4, 139.3, 136.2, 135.1, 130.1, 129.3, 129.3,
128.9, 128.7, 128.0, 128.0, 126.8, 125.8, 125.2, 124.4, 121.4,
38.4, 19.7; MS m/z 285 (M+); HRMS m/z calcd for C21H19
N
285.1517 (M+), found 285.1513.
(E)-2-[1-ter t-Bu tyld im eth ylsiloxy-1-m eth yl-3-(2-m eth -
ylp h en yl)-2-h ep ten yl]p yr id in e (58): Rf ) 0.65 (25% Et2O
(E)-2-[5-ter t-Bu tyld im eth ylsiloxy-2-(2-m eth ylp h en yl)-
1-p en ten yl]p yr id in e (40): Rf ) 0.57 (50% Et2O in hexane);
in hexane); IR (neat) 3058, 2955, 2857, 1729, 1644, 1587 cm-1
;
1
IR (neat) 3070, 2930, 2857, 1634, 1585, 1558 cm-1; H NMR
1H NMR (400 MHz, CDCl3) δ 8.58-8.56 (1H, m), 7.86 (1H, d,
J ) 8.0 Hz), 7.69 (1H, ddd, J ) 8.0, 8.0, and 1.6 Hz), 7.16-
7.10 (4H, m), 7.07-7.05 (1H, m), 5.77 (1H, s), 2.31 (3H, s), 2.29
(1H, dt, J ) 12.8 and 4.4 Hz), 1.98 (1H, dt, J ) 12.8 and 4.4
Hz), 1.84 (3H, s), 1.01 (9H, s), 0.92-0.68 (4H, m), 0.57 (3H, t,
J ) 7.2 Hz), 0.19 (3H, s), 0.07 (3H, s); 13C NMR (100 MHz,
CDCl3) δ 168.7, 148.0, 143.7, 143.3, 137.7, 135.9, 135.5, 129.9,
128.5, 126.3, 125.1, 121.1, 120.4, 77.6, 32.7, 31.7, 28.6, 26.1,
26.1, 26.1, 22.9, 19.8, 18.4, 13.7, -2.1, -2.2; MS m/z 409 (M+);
HRMS m/z calcd for C26H39NOSi 409.2801 (M+), found 409.2811.
(E)-2-[1-ter t-Bu tyld im eth ylsiloxy-1-m eth yl-3-(2-m eth -
ylp h en yl)-2-h ep ten yl]p yr a zin e (59): Rf ) 0.68 (50% Et2O
(300 MHz, CDCl3) δ 8.58-8.55 (1H, m), 7.61-7.52 (5H, m),
7.39-7.24 (7H, m), 7.19-7.11 (4H, m), 7.07-7.02 (1H, m), 6.36
(1H, s), 3.64 (2H, t, J ) 6.0 Hz), 3.04-2.99 (2H, m), 2.34 (3H,
s), 1.71-1.62 (2H, m), 1.00 (9H, s); 13C NMR (75 MHz, CDCl3)
δ 156.6, 149.1, 147.7, 143.7, 135.8, 135.4, 135.4, 135.4, 135.4,
134.8, 133.8, 133.8, 130.0, 129.3, 129.3, 128.6, 128.4, 127.4,
127.4, 127.4, 127.4, 126.8, 125.3, 123.9, 120.9, 63.9, 31.0, 29.4,
26.9, 26.9, 26.9, 20.1, 19.3; MS m/z 491 (M+); HRMS m/z calcd
for C33H37NOSi 491.2644 (M+), found 491.2658.
(E)-2-[5-Hyd r oxy-2-(2-m eth ylp h en yl)-1-p en ten yl]p yr i-
d in e (41): Rf ) 0.34 (50% AcOEt in hexane); IR (neat) 3286,
2932, 1634, 1589, 1563 cm-1
;
1H NMR (400 MHz, CDCl3) δ
in hexane); IR (neat) 2957, 2858, 1644 cm-1 1H NMR (300
;
8.57 (1H, dd, J ) 5.2 and 1.2 Hz), 7.69 (1H, ddd, J ) 7.9, 7.9,
and 1.2 Hz), 7.22-7.13 (6H, m), 6.53 (1H, brs), 6.43 (1H, s),
3.74 (2H, t, J ) 5.2 Hz), 3.09 (2H, t, J ) 6.4 Hz), 2.36 (3H, s),
1.63 (2H, dt, J ) 6.4 and 5.2 Hz); 13C NMR (100 MHz, CDCl3)
δ 155.8, 148.1, 147.6, 143.0, 137.1, 134.9, 130.5, 129.0, 128.4,
127.1, 125.5, 125.4, 121.6, 59.6, 29.2, 27.7, 19.8; MS m/z 253
(M+); HRMS m/z calcd for C17H19NO 253.1467 (M+), found
253.1474.
MHz, CDCl3) δ 9.13 (1H, s), 8.50 (1H, d, J ) 2.4 Hz), 8.44 (1H,
d, J ) 2.4 Hz), 7.15-7.02 (4H, m), 5.73 (1H, s), 2.31-2.21 (1H,
m), 2.28 (3H, s), 2.04-1.94 (1H, m), 1.82 (3H, s), 0.99 (9H, s),
0.90-0.66 (3H, m), 0.56 (3H, t, J ) 7.2 Hz), 0.39-0.25 (1H,
m), 0.19 (3H, s), 0.09 (3H, s); 13C NMR (75 MHz, CDCl3) δ
163.9, 144.2, 143.1, 143.0, 142.6, 142.0, 136.6, 135.3, 130.0,
128.3, 126.5, 125.2, 76.8, 32.8, 31.7, 28.7, 26.0, 26.0, 26.0, 22.8,
19.8, 18.3, 13.7, -2.1, -2.2; MS m/z (M+); HRMS m/z calcd
for C25H38N2OSi 410.2753 (M+), found 410.2757.
(E)-2-[4-H yd r oxy-2-(2-m et h ylp h en yl)-1-b u t en yl]p yr i-
d in e (42): Rf ) 0.44 (50% Et2O in hexane); IR (neat) 3242,
2853, 1634, 1590, 1562 cm-1 1H NMR (300 MHz, CDCl3) δ
;
Ack n ow led gm en t. We would like to thank NSERC,
Merck Frosst, the ORDCF, and the University of Tor-
onto for valuable support of our programs. M.Y. ac-
knowledges support in the form of Postdoctoral Fellow-
ships from the Uehara Memorial Foundation. We are
grateful to Dr. Koichiro Fukuoka for helpful suggestions
and the synthesis of ligand 3.
8.54 (1H, dd, J ) 5.1 and 1.8 Hz), 7.71 (1H, ddd, J ) 7.8, 7.8,
and 1.8 Hz), 7.26-7.19 (6H, m), 7.01 (1H, brs), 6.56 (1H, s),
3.81 (2H, t, J ) 5.7 Hz), 2.98 (2H, t, J ) 5.7 Hz), 2.38 (3H, s);
13C NMR (75 MHz, CDCl3) δ 154.9, 147.7, 146.4, 143.3, 137.1,
135.2, 130.2, 129.5, 128.6, 127.2, 125.4, 124.6, 122.0, 60.3, 35.7,
19.8; MS m/z 239 (M+); HRMS m/z calcd for C16H17NO
239.1310 (M+), found 239.1304.
(E,E)-2,6-Bis[2-(2-m et h ylp h en yl)-1-h exen yl]p yr id in e
(43): Rf ) 0.61 (10% Et2O in hexane); IR (neat) 3015, 2956,
2858, 1634, 1558 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.60 (1H,
dd, J ) 7.8 and 7.8 Hz), 7.21-7.14 (8H, m), 7.08 (2H, d, J )
7.8 Hz), 6.36 (2H, s), 2.93 (4H, t, J ) 7.2 Hz), 2.37 (6H, s),
1.43-1.23 (8H, m), 0.82 (6H, t, J ) 7.2 Hz); 13C NMR (75 MHz,
Su p p or t in g In for m a t ion Ava ila b le: 1H and 13C NMR
spectrum of 12-16, 22, 24, 25, 27, 29, 30, 32a -f, 35-44, 49,
and 54-60 and ROESY spectrum of 32e. This material is
J O0205255
J . Org. Chem, Vol. 68, No. 3, 2003 769